Aberdeen Group’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-73,219
Closed -$39.1M 990
2020
Q4
$39.1M Sell
73,219
-35,011
-32% -$17.2M 0.1% 195
2020
Q3
$52M Buy
108,230
+6,697
+7% +$3.28M 0.14% 140
2020
Q2
$45.9M Buy
101,533
+32,423
+47% +$14.5M 0.12% 149
2020
Q1
$30M Buy
+69,110
New +$30.9M 0.1% 175

Other funds holding CHE

Aberdeen Group's CHE Position: Q1 2021 in Review

Aberdeen Group sold out of Chemed (CHE) in Q1 2021, closing a stake of 73,219 shares — an estimated $39.1M sold.

Aberdeen Group first reported a position in CHE in Q1 2020 and held it in 4 quarters. The position peaked at $52M in Q3 2020. 421 funds tracked by Wall St. Rank hold CHE as of Q1 2021.

  • Aberdeen Group reported no remaining Chemed position as of Q1 2021 after selling out during the quarter.
  • Aberdeen Group sold 73,219 Chemed shares in Q1 2021, an estimated $39.1M.
  • Aberdeen Group first reported a position in Chemed in Q1 2020 and held it in 4 quarters.
  • Aberdeen Group's Chemed position peaked at $52M in Q3 2020.
  • 421 funds tracked by Wall St. Rank held Chemed as of Q1 2021.

Based on Aberdeen Group's 13F filing for Q1 2021, filed 6 May 2021.